Beruflich Dokumente
Kultur Dokumente
DIE MARK
Corporate headquarters:
1600 Faraday Avenue Carlsbad, CA 92008 USA Tel: 760 603 7200 Fax: 760 602 6500 Toll Free Tel: 800 955 6288 E-mail: tech_service@invitrogen.com www.invitrogen.com
European headquarters:
Invitrogen Ltd 3 Inchinnan Business Park Fountain Drive Paisley PA4 9RF, UK Tel: +44 (0) 141 814 6100 Fax: +44 (0) 141 814 6260 E-mail: eurotech@invitrogen.com
710-021849 070803
10M
AGGG
TTCCC
TOPO
3 phosphate
CCCTT
GGGA
PCR Product
TOPO
CCCT T
GGGA A
TOPO
PCR Product
A AGGG
T TCCC
Topoisomerase I
is released
TOPO
Ligation complete
AAGGG
TTCCC
TOPO
CCCTT
GGGAA
3 phosphate
TOPO
PCR Product
CCCTT
GGGAA
TOPO
PCR Product
AAGGG
TTCCC
Topoisomerase I
is released
TOPO
Ligation complete
5 minutes at
room temperature
AAGGG
TTCCC
TOPO
CCCTT
GGGAAGTGG
3 phosphate
CACC
GTGG PCR Product
TOPO
TOPO
CCCTT CACC
GGGAA GTGG PCR Product
TOPO
GTGG
AAGGG
TTCCC
Topoisomerase I
is released
Ligation complete
~1~
www.invitrogen.com
gel purification*
CACC
PCR Product
OR
2. Incubate 5 minutes at
room temperature.
PCR Product
PCR Product
TOPO
TOPO
55
TOPO
Cloning
Vector
5
10
50
45
15
20
40
35
30
25
*The TOPO XL PCR Cloning Kit requires a 15-minute gel purification step.
Steps
TOPO TA Cloning
TA/UA Cloning
Restriction Enzyme
Cutback and Ligation
Order or prepare
PCR Primers
Prepare or purchase
competent cells
1) Purchase: 0 hours
2) Prepare: 6 hours
5 minutes
1 hour
2 to 23 hours
60% to 80%
~ 60%
1 to 12 hours
2 to 23 hours
5 minutes
~2~
Amplification Enzyme
Product
Page no.
General subcloning
Cloning
Platinum Taq
in vitro transcription
TOPO TA
DNA Polymerase
Sequencing
High-throughput studies
13
13
13
Proofreading polymerase:
General subcloning
Platinum Pfx
in vitro transcription
DNA Polymerase
Sequencing
Blunt
TOPO
High-throughput studies
HTP Zero
PCR Cloning Kit
for Sequencing
HTP Directional TOPO pENTR vectors
13
Proofreading polymerase:
10
Platinum Pfx
DNA Polymerase*
11
12
General subcloning
in vitro transcription
Sequencing
13
DNA Polymerase
High Fidelity
* The use of Platinum Pfx DNA polymerase requires a PCR purification step prior to cloning.
These products may be covered by one or more Limited Use Label Licenses (See the Invitrogen catalog or our web site, www.invitrogen.com). By
the use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses.
Kit Name
Application
Template
Page no.
TOPO Shotgun
Subcloning Kit
14
15
~3~
www.invitrogen.com
TOPO
SP6
Nsi I
Hind III
Kpn I
Sac I
BamH I
Spe I
BstX I
EcoR I
pCRII-TOPO
T
T
recombinants. The
T7
TOPO
EcoR I
EcoR V
BstX I
Not I
Xho I
Nsi I
Xba I
Apa I
pCR2.1-TOPO
include:
Hind III
Kpn I
Sac I
BamH I
Spe I
BstX I
EcoR I
TOPO
T
T
lacZ
EcoR I
EcoR V
BstX I
Not I
Xho I
Nsi I
Xba I
Apa I
Cloning
T7
TOPO
pCR-TOPO
3.9 kb
yc i
n
pUC ori
i
or
Am
am
pic
illin
r
Vecto
Topoisomerase I
5
3
Topoisomerase I
T
3
Topoisomerase I
T
Vecto
PCR
Product
A
T
Vecto
r
Vector
3
A
Taq-amplified
PCR Product
~4~
Topoisomerase I
pCR-Blunt
II-TOPO
SP6
vector
P lac
TOPO
EcoR I
Pst I
EcoR V
Not I
Xho I
Nsi I
Xba I
Dra II
Apa I
Nsi I
Hind III
Asp718 I
Kpn I
Ecl136 II
Sac I
BamH I
Spe I
EcoR I
T7
TOPO
lacZ
ccd
B
Kanamycin
pCR-Blunt IITOPO
3.5 kb
Ze ocin
TOPO
ccdB
lacZ
ccdB
Blunt DNA
lacZ
Blunt DNA
ccdB
ground colonies.
~5~
www.invitrogen.com
T
T
recombinants.
Pla
It contains
EcoR I
Pst I
EcoR V
Not I
Xho I
Nsi I
Xba I
Dra II
Apa I
M13
Mlu I
Nsi I
Hind III
Kpn I
Ecl136 II
Sac I
BamH I
Spe I
EcoR I
TOPO
lacZ
cc d
T7
TOPO
B
pCR-XLTOPO
Kanamycin
pUC ori
3.5 kb
TOPO
Crystal
Violet
Ethidium
Bromide
Total Colonies
(KanR)
275
15
Colonies w/insert
(KanR-AmpR)
258
Percent
Recombinants
94%
60%
When using chemically competent E. coli, you can expect 70% recombinants. For the best results, electrocompetent cells are recommended
because electroporation yields higher transformation efficiencies than chemical methods and does not bias against larger constructs.
The TOPO XL PCR Cloning Kit has been tested with Expand and eLONGase.
~6~
M13
T3
TOPO
33 bp
33 bp
Spe I
Sse8387 I
Pme I
EcoR I
73 bp
Taq-amplified
PCR Product
M13
pCR4-TOPO
M13
pCR4Blunt-TOPO
TOPO
M13
T3
33 bp
TOPO
33 bp
EcoR I
Not I
73 bp
Spe I
Sse8387 I
Pme I
EcoR I
T7
Blunt-end
PCR Product
Choice of vectors
60 bp
T
EcoR I
Not I
lacZ
cc
dB
Pla
ri
cloning Taq-amplified PCR products. The pCR4BluntTOPO vector supplied in the Zero Blunt TOPO PCR
PCR products amplified with proofreading polymerases.
4.0 kb
Am
p ici
T7
TOPO
Kana
my
cin
pCR4- and
pCR4BluntTOPO
60 bp
ll ii n
TOPO
For shotgun sequencing and cloning unknown sequences, refer to TOPO Cloning Kits for Genomic Analysis,
pages 14 and 15
~7~
www.invitrogen.com
Domain of interest
Domain of interest
RE2
RE1
RE2
RE1
1. Digest with
restriction enzymes
RE1
RE2
ATG
Epitope
moter
Pro
A
A
+
moter
Pro
2. Ligate Overnight
3. Transform
RE1
T
T
Epitope
RE2
Epitope
moter
Pro
moter
Pro
RE = Restriction enzyme
= Non-coding sequence
~8~
Epitope
TOPO
you will:
Save time TOPO Cloning of your PCR product takes
PCR
PCR
5 minutes
1 hour
Gel purify DNA fragment.
Dephosphorylate linearized vector
Transformation
13 hours
2 hours
Screen 5 colonies
Overnight ligation
15 hours
12 hours
EXPRESSION
Transformation
13 hours
Screen 20 colonies
Time Savings:
20 hours
20 hours
EXPRESSION
Total time: 48 hours
Figure 13 Directional cloning of human open reading frames into pcDNA3.1D/V5-His-TOPO vector
Clone
% Correct
18
90%
20
100%
19
95%
~9~
10
-gal
allows you to regulate transcription with IPTG. The additional lacO element found in the T7lac promoter used in
the pET vectors further reduces the basal expression levels while maintaining strong transcriptional activity upon
induction with IPTG. Reported yields of recombinant
proteins from the pET vectors are typically in the range
of tens to hundreds of milligrams per liter of
culture (Figure 14). The pET Directional TOPO
Expression Kits offer:
Advanced cloning technology
U=Uninduced I=Induced
The lacZ gene was cloned directionally into pET100/D-TOPO, pET101/D-TOPO,
and pET102/D-TOPO vectors and cloned using the restriction digest method into
pET15b and pET32a vectors. Constructs were transformed into BL21 Star(DE3)
E. coli. A single colony from each transformation was used to inoculate 1 ml LB
medium supplemented with 100 g/ml ampicillin. Induction with 1 mM IPTG was
performed at OD600=0.5. Two and one-half hours post induction, cultures were
harvested by centrifugation. Pellets were resuspended in 300 l sample buffer. Ten
microliters of each sample was analyzed on a 4-20% Novex Tris-Glycine gel.
Note: pET15b contains an N-terminal 6xHis tag while pET32a contains
an N-terminal thioredoxin fusion and a C-terminal 6xHis tag.
Lanes 1 and 2: pET15b/lacZ
Lanes 3 and 4: pET101/D-TOPO/lacZ
Efficiency
8
1 x 10
Quantity
Cat. no.
20 x 50 l
C6010-03
Efficiency
8
>1 x 10
~ 10 ~
Quantity
Cat. no.
20 x 50 l
C6070-03
TOPO
BGH pA
p U C ori
pA
40
SV
l li n
5.5 kb
Neomy
cin
A m pi c i
pcDNA3.1D/
V5-His-TOPO
ri
40 o
SV
Stop
P CM
6xHis
Pme I
V5 epitope
Age I
TOPO
EcoR V
BstX I
Not I
Xho I
Xba I
Apa I
Sac II
T7
Hind III
Asp718 I
Kpn I
BamH I
vectors. These constructs were each transfected into 7.5 x 104 COS-7 cells using the
calcium phosphate method. Forty-eight
hours post transfection, cells were harvested. Ten micrograms of total protein
was loaded on each lane of an SDS-PAGE
gel. Expression was analyzed by western
blot using an anti--gal antibody. Lane 1:
Mock; Lane 2: pcDNA3.1/V5-His/lacZ;
Lane 3: pcDNA3.1D/V5-His/lacZ.
TOPO
CCC TT
GGG AAG TG G
AAG GGC
TTC CCG
Xho I
Apa I
Sac II
Sfu I
BamH I
Spe I
BstX I
The
ViraPower
V5 epitope
Stop
TOPO
PSV4
P CM
RR
L
P RSV/5 TR
pLenti6/V5D-TOPO
7.0 kb
LT
RR
pU
Ampicillin
pA
40
SV
or
U3
/3
idin
stic
Bla
EM
interest
~ 11 ~
www.invitrogen.com
gene 10 RBS
AAG GGT
TTC CCA
Asc I
Not I
TOPO
CCC TT
TOPO
pENTR/D-TOPO
Asc I
Not I
CC C T T
GGG AAG TGG
att
L2
pENTR
pcDNA/GW/D-TOPO Vectors
2.6 kb
Kana m
y ci
cant cloning and screening time. Once your gene of interest is cloned into the vector, it will immediately express
from the built-in CMV promoter. This powerful promoter
drives high-level constitutive expression in a wide variety
TOPO
Asc I
Not I
attB1
V5
ep
pe
ito
TOPO
attB2
pU C
ori
PS
0
V4
pA
40
)
PO
om
TO )
ycin
/ DO
B la
(p c D N A 3. 2 / G W
P
O
s ti c
D-T
id in
(pc D N A 6. 2 / G W /
ne
~ 12 ~
EM
SV
TkpA fl origin
a mp
pcDNA/GW/
D-TOPO
nel pipette (Table 5). With the speed and high efficiency
reactions of
TOPO
Reactions
Cat. no.
pCR2.1-TOPO
Bulk
MultiShot
MultiShot StripWell
500
480
480
K4500-500
K4500-480
K4500-05
pCRII-TOPO
Bulk
MultiShot
MultiShot StripWell
500
480
480
K4600-500
K4600-480
K4600-05
pCR4-TOPO
Bulk
MultiShot
MultiShot StripWell
500
480
480
K4575-500
K4575-480
K4575-05
pCR4Blunt-TOPO
Bulk
MultiShot
MultiShot StripWell
500
480
480
K2875-500
K2875-480
K2875-05
pENTR/D-TOPO
Bulk
MultiShot StripWell
500
480
K2400-500
K2400-480
pENTR/SD/D-TOPO
Bulk
MultiShot StripWell
500
480
K2420-500
K2420-480
Description
HTP TOPO TA Cloning Kit
* For more information on these vectors, see the catalog or visit our web site at www.invitrogen.com/topo
Bulk (five 5-ml aliquots)
MultiShot (five 96-well plates)
MultiShot StripWell (five stripwell plates)
~ 13 ~
www.invitrogen.com
Hours
10
12
14
16
Traditional
Shotgun
Procedure
TOPO Shotgun
Subcloning Kit
Shear DNA
Gel Purify
Clone
~ 14 ~
5
ACGT
TGCA
Step 2
5
2. Dephosphorylate the
DNA to allow ligation
of the TOPO Linker.
TGCA
ACGT
Step 3
3
5
GSP1
ACGT
TGCA
Step 4
5
A
5 TTCCC
GSP1
ACGT
TOPO Linker
3
5
TOPO
Step 5
GSP1
ACGT
GSP2
A
T
TOPO Linker
5
LinkAmp Primer 1 or 2
Known DNA
Unknown DNA
the
TOPO
TOPO
Linker is
LinkAmp Primer 2
TAGAAGGCACAGTCGAGGACTTATCCTAGCCTCTGAATACTTTCAACAAGTTACACCCTT
AAAAAAAATCTTCCGTGTCAGCTCCTGAATAGGATCGGAGACTTATGAAAGTTGTTCAATGTGGGA
~ 15 ~
TOPO
TOPO
www.invitrogen.com
Clone it today
With unrivaled consistency and speed, TOPO Cloning Kits
ensures that youll get your clones the first time, every time.
References:
1. Shuman, S. (1994) J. Biol. Chem. 269: 32678-32684.
2. Clark, J.M. (1988) Nuc. Acids Res. 16: 9677-9678.
3. Mead, D. et al. (1991) Bio/Techniques 9: 657-663.
4. Bernard, P. and Couturier, M. (1992) J. Mol. Biol. 226: 735-745.
5. Bernard, P. et al. (1993) J. Mol. Biol. 234: 534-541.
6. Rand, K.N. (1996) Elsevier Trends Technical Tips Online.
~ 16 ~
DIE MARK
Corporate headquarters:
1600 Faraday Avenue Carlsbad, CA 92008 USA Tel: 760 603 7200 Fax: 760 602 6500 Toll Free Tel: 800 955 6288 E-mail: tech_service@invitrogen.com www.invitrogen.com
European headquarters:
Invitrogen Ltd 3 Inchinnan Business Park Fountain Drive Paisley PA4 9RF, UK Tel: +44 (0) 141 814 6100 Fax: +44 (0) 141 814 6260 E-mail: eurotech@invitrogen.com
710-021849 070803
10M